Close Menu

NEW YORK (GenomeWeb) – Consumer wellness startup Onegevity Health said today that it is incorporating Gencove's low-pass genome sequencing and analytics into its service.

Under the partnership, Gencove, a spinout from the New York Genome Center, will provide its low-pass sequencing solution to Onegevity's multi-omic artificial intelligence platform and services. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.